文献速递细菌感染、耐药与抗菌药物

淋病奈瑟菌抗菌药物耐药检测方法综述

Review of Methods for Detecting Antimicrobial Resistance of Neisseria gonorrhoeae.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该系统性综述纳入80篇文献,评估淋病奈瑟菌表型与分子药敏检测方法。琼脂稀释法仍为金标准但操作繁琐;分子法可可靠预测环丙沙星敏感性(gyrA S91F突变),对其他药物预测准确性有限。培养法药敏仍是最可靠方法,分子法需更广泛验证。

要点

  • 琼脂稀释法为淋球菌药敏金标准,但 labor-intensive 限制常规使用。
  • 分子法通过 gyrA S91F 突变可靠预测环丙沙星敏感性。
  • 其他抗菌药物因多基因耐药机制,分子法预测准确性有限。

核心结论

  • 培养法药敏仍是检测淋球菌耐药最可靠的方法。
  • 分子法有针对性用途,主要限于环丙沙星,需更广泛验证。

研究设计与样本

  • 系统性综述,检索 Medline、Embase、Cochrane、CINAHL 和 Scopus(2009-2024)。
  • 共识别3136篇文献,80篇符合纳入标准。

主要发现

  • 琼脂稀释法为金标准,但工作流程 labor-intensive 限制常规使用。
  • 纸片扩散法、梯度扩散法和肉汤微量稀释法可行,但与琼脂稀释法相比存在方法和药物依赖性变异。
  • 分子检测通过 gyrA S91F 突变可靠预测环丙沙星敏感性,其他药物预测准确性有限。
  • 下一代测序扩展耐药决定簇检测,但尚不适用于快速临床决策。

临床怎么用

  • 培养法药敏应作为淋球菌耐药检测的主要手段。
  • 分子法可针对性用于环丙沙星敏感性预测。
  • 需标准化替代表型方法、改进分子标志物表征以支持耐药指导治疗。

局限性

  • 分子药敏受耐药决定簇验证不完整限制。
  • 替代表型方法存在方法和药物依赖性变异,受培养基和制造商差异影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neisseria gonorrhoeae (GC) rapidly develops antimicrobial resistance, complicating treatment and surveillance. Although interest in resistance-guided therapy is increasing, most infections are treated empirically. Culture-based antimicrobial susceptibility testing (AST) remains essential but is limited by the fastidious nature of GC. Molecular AST shows promise but is constrained by incomplete validation of resistance determinants. METHODS: We conducted a systematic review of phenotypic and molecular AST methods for GC using predefined search strategies across Medline, Embase, Cochrane, CINAHL, and Scopus (2009-2024). Of 3136 unique manuscripts identified, 80 met inclusion criteria. Data extraction captured test methods, performance characteristics, and reported strengths and limitations. RESULTS: Agar dilution remains the gold standard for GC AST, though its labor-intensive workflow limits routine use. Disk diffusion, gradient diffusion, and broth microdilution offer feasible alternatives but show method- and drug-dependent variability compared with agar dilution, influenced by media and manufacturer differences. Molecular assays reliably predict ciprofloxacin susceptibility via the gyrA S91F mutation, whereas predictive accuracy for other antibiotics is limited due to multigenic resistance mechanisms. Next-generation sequencing expands detection of resistance determinants but is not yet practical for rapid clinical decision-making. CONCLUSIONS: Culture-based AST remains the most reliable approach for detecting GC resistance. Molecular methods have targeted utility, primarily for ciprofloxacin, and require broader validation. Standardizing alternative phenotypic methods, improving molecular marker characterization, and strengthening surveillance capacity will be essential to support resistance-guided therapy.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mitchell KK, Smith AC, Ayala JC, et al. Review of Methods for Detecting Antimicrobial Resistance of Neisseria gonorrhoeae. Clin Infect Dis. 2026. PMID: 41733545. doi:10.1093/cid/ciaf706

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。